Chirag Patel

Chirag Patel, MD, is a Principal Scientist at Century Therapeutics, Inc., specializing in Translational Development since January 2025. Previously, Chirag Patel served as a Senior Scientist at Bristol Myers Squibb from August 2016 to January 2025, contributing to autoimmunity drug discovery. Prior roles at Bristol Myers Squibb included positions focused on autoimmunity and immuno-oncology drug discovery. From 2010 to 2016, Chirag Patel was a Sr. Principal Researcher at Eisai US, investigating cancer biology for therapeutic monoclonal antibodies. Within the pharmaceutical field, Chirag Patel also worked as a Scientist at Merck from 2008 to 2010, focusing on monoclonal antibodies. Chirag Patel began a career in research as a Fellow at Thomas Jefferson University from 2003 to 2007, concentrating on small molecule therapies for GI motility disorders and tumorigenic protein interactions. Academic credentials include a Master of Science in Molecular Biology from Long Island University and an MBBS from Maharaja Sayajirao University of Baroda.